Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
The deal would fold the FDA-cleared Hotwire system, and the team behind Farapulse, into J&J’s expanding cardiac ablation business.
Tag Archives: Johnson & Johnson
R&D Operations Bottlenecks in Large Life Sciences Organizations: What can MedTech Leaders Do?
How is software-enablement — connected devices and artificial intelligence — reshaping how products are conceived, developed, and deployed in clinical practice? Fragmented operations in large MedTech organizations are not keeping pace with the complexity of products in their pipelines.
GE, J&J to Split Off Healthcare, Medical Device/Pharma Businesses
The global giants believe the strategic moves will make their businesses stronger and more profitable long-term.
J&J CEO Alex Gorsky to Step Down at Start of 2022, Successor Named
In a company release, Gorsky stated the decision comes at the right time both professionally as well as personally, as he must focus on family health. Current Vice Chairman of the company’s executive committee, Joaquin Duato, will serve as new CEO, effective January 3, 2022.
Pediatric Medical Devices Address COVID-19, 16 Companies Compete for Grants
The winning innovators will receive grant awards of upwards of $50,000.
COVID-19 Will Forever Change MedTech and Healthcare
Medtech companies will need to collaborate more closely with other parties in healthcare, as the aftermath of the coronavirus pandemic will have a comprehensive reach throughout the entire ecosystem. MTI speaks with Johnson & Johnson VP Raymond Fryrear, M.D. on the topic.
U.S. Companies Donate Nearly $27 Million in Medical Products to Aid in COVID-19 Outbreak in China
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
J&J Must Pay $344 Million for Marketing of Pelvic Mesh in California Case
The state’s attorney general said J&J put its profits “ahead of the health of millions of women”.
Another Cash Deal: J&J’s Ethicon to Acquire Auris Health for $3.4 Billion
The deal will help J&J speed up its entry into the robotics market.
J&J Restructure: Will Cost Cuts Affect Suppliers?
The company just announced that it is restructuring its global supply chain.